allyl-(6-diazo-5-oxo)-norleucyl-(6-diazo-5-oxo)-norleucine has been researched along with African Sleeping Sickness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusawa, T; Ichimura, M; Ishiyama, A; Masuma, R; Namatame, M; Nishihara, A; Omura, S; Otoguro, K; Shiomi, K; Takahashi, Y; Yamada, H | 1 |
1 other study(ies) available for allyl-(6-diazo-5-oxo)-norleucyl-(6-diazo-5-oxo)-norleucine and African Sleeping Sickness
| Article | Year |
|---|---|
In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Topics: Animals; Cell Line; Dipeptides; Drug Discovery; Female; Humans; In Vitro Techniques; Methylglucosides; Mice; Mice, Inbred ICR; Molecular Structure; Parasitic Sensitivity Tests; Soil Microbiology; Terpenes; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2008 |